The use of the Oxford-AstraZeneca vaccine in those under 30 is to be limited due to concerns over blood clots – but what exactly is the risk and how does it compare?
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.


